FDA Inspection 998173 — New Haven Pharmaceuticals, Inc.
The FDA completed an inspection of New Haven Pharmaceuticals, Inc. on Jan 18, 2017 in North Haven, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- North Haven, CT (United States)